Both Eli Lilly $LLY (-0.03%) and Novo Nordisk $NVO (+0.1%) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (-0.03%) is on track to become the first trillion dollar drug-maker...😯